11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
We have been getting accountability all wrong in the compliance profession. It’s not a set of tasks...
Read More >
I’m not a big fan of target-date funds and that bias goes back to the implosion of the stock market...
Read More >
At the end of 2019, Dutch department store chain HEMA announced it was going to stop using fingerpri...
Read More >
Employers sometimes allow their employees to first take paid time off, or other accrued time, before...
Read More >
In Ferra v. Loews Hollywood Hotel, LLC, the California Court of Appeal considered the method for det...
Read More >
Employers, you are not out of the CCPA woods yet. If you have been tracking the proposed amendments...
Read More >